Main: +45 31 10 91 91
Fax: +45 77 31 15 09
CVR/VAT no. 31348854
Ordering: +45 29 13 42 24
In Immudex R&D, we work in project teams on many parallel projects to develop new products, assays, and applications. To succeed, you should be experienced and willing to quickly acquire new skills as needed. You will be working in the laboratory on the assigned tasks from different projects together with one or more scientists. Main tasks and responsibilities will be centered on development and testing of new proteins and assays to support research and development projects within R&D and Custom Project Service.
You are a laboratory technician or biomedical laboratory scientist by training or have a similar educational background with at least 5 years hands-on experience from a research laboratory.
You master recombinant protein production in E. coli, including protein expression, refolding, purification, and protein analysis being familiar with SDS-PAGE, ELISA, and FPLC (ÄKTA) analysis. Hands-on experience with molecular biology and cell culture techniques as well as cellular assays like flow cytometry, ELISpot, and other immunoassays will be an advantage.
You have the following qualifications:
As a person, you are a strong team player, but can also work independently, and you thrive with a high pace without losing track of the details. You are a good communicator and enjoy a flexible work environment, where you do not always know what to expect the next day. You are open-minded and have a good sense of humor.
We offer an interesting laboratory technician position with training and development opportunities in an international and diverse organization, where we care for each other and care about making a difference to human health.
The position is permanent and is based at Immudex’ headquarters in Virum:
As we process applications on a continuous basis, please apply to this position as soon as possible by sending your CV and cover letter in English to firstname.lastname@example.org.
Application deadline: May 21, 2021.
If you have any questions about the position, please contact Senior Scientist Thomas Holberg Blicher at +45 3113 7325 or email@example.com.
Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex manufactures MHC Dextramer® for the detection of antigen-specific T cells. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
Immudex' MHC Dextramer® products are utilized for the quantification or sorting of antigen-specific T cells in life science research, in-vitro diagnostics, as well as the development of immunotherapeutics and vaccines. The primary focus is research-use-only products for the immune monitoring of immunotherapy development and monitoring of CMV cellular immunity in transplant and other immune-deficient patients. In Europe, the CE-marked Dextramer® CMV Kit is approved for in vitro diagnostic use for the quantification of CMV-specific T cells. USA FDA 510(k) clearance for the CMV kit was granted March 2017. GMP Grade reagents are available.
Our state-of-the-art dCODE Dextramer® reagents enable massive multiplexing of antigen-specific T-cell detection. Detection of over 1000 CD8+ T-cell specificities from a single blood sample has been achieved.